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ABSTRACT 
l'ercohaatl klitlis d~!zgan tlosis tunggal dari Jorlit (Compoutzd 16842) terhadap 60 penderita cacing 
tarrlbang tclah dilakilkan di  Iljung I'andang, Sulawesi Selatan. 
Pt~t7derita twschut tcrdiri dari 24 anak-anak dun 36 orang de\t1ro~. 
I'cJrneriksaar~ tirlja dilakukan dengan cara penzcriksaarl Iatzgsurzg sediaan basah dun pemhiakan 
larva cara llaradu-rllori sehclurn dun 2 - 4 rninggu setclalz pengobatan. 
Y O  R dari 60 kasus tersrhut tcrkena itzf'eksi dcngarl ,Vec.lrtor anzericana sedang yang 10 % ter- 
ketza inli.ksi car?lplrrarl dengan iVecator anlericatlus dun Atzkylostonza duodenale. 
i'ada kelnnzpok prrtama tcrdiri dari pendcrita berurrlur antara 5 -- I 0  tahun diperoleh penyem- 
buhar~ parasitoiogis 81,8 F4, pada kelompok kcdua rerdiri dari pendcrita berunzur antara 11 - 1 5  tahun 
dipcrolch Y2,3 7; dun patla kclompok I~rtiga tcrdiri dari pcnderita herumur antara 16 - 50 tahun di- 
pc~rolch 86, I %, schingga dalar?z kesrlumhan didapatkarl penyctnbuhan 86,7 %. Dalarrz pada itu ditemu- 
kan pcnurunan Iziturzgarz tclur vatu-rata 85, l  ?% dun penurunan penctasan rata-rata 93,U %. 
Drngaran percobaan ini tclah ditutanjukkan, bahwa Jonit merupakarz ohat cacitzg yang ejektip dan- 
urrzun trrhatiap pcwgohataran haik Necator atr~cricanus r?iau;~utz .lnk~~lostonza Guc~tlerzale. 
t*;/ek sampitzgalz scpcrti mual, murus, muntah, rasa perut tidak enak dun pusing, adalah ringan 
darz sambil lalii patla hari pcrtanza pcngobamtz dun tidak membutuhkan pengohatan khusus. 
Dalan? .kesc~:zo-uhan obat ini nampak dapat ditcrinza haik dengan cara dosis tunggal dun berguna 
dalarn skema pengohatan tnassal urztuk perrzberantasan cacing tambang. 
INTRODUCTION 
I-iookworm disease is widespread and is one 
of the most important diseases of man. It  is 
found nearly in all sub-tropical and tropicai 
countries (warm, moist climate, between 4 0  
Northern and 35" Southern latitude). The 
number (of hookworm infections is probably 
still near the past estimate of 700  million. 
( ~ 7 )  
Light infections produce no recognizable 
symptoms. but the continuous loss of blood 
in chronic or heavy chronic hookworm infec- 
tion may give microcytic hypochromic anac- 
mia, and acconipanied by malnutrition it may 
rob energy, weaken the natural protective 
mechanism of the host and cause many phy- 
sical and mental problems. 
,Vecator anzc,ricanu.s and Anc:\~lostor?za duo- 
derzalc are parasites almost exclusively of man. 
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Whenever these infections are endemic, they 
are the consequence of unsanitary disposal o f  
human feces. It  has been found also that  of 
these 2 species each can be encountered epi- 
demiologically as a sole species inhabiting an 
area or that both of them jointly inhabit thc 
same area. 
Ancylostoma duodenale, the Old World 
hookworm, is prevalent in southern Europe, 
northern Africa, northern lndia,China and Ja- 
pan; it  is also found in southern India, Indo- 
nesia, Birma, Malaysia, the Philippines, Aus- 
tralia and Paraguay. 
Necator americanus, the New M drld hook- 
worm, is the predominant human hookworm 
in Asean countries, Polynesia, Micronesia, 
Melanesia, Central and South Africa, the 
southern United States, Central and South 
America. (5) 
Jonit (Compound 16842) is the trade name 
used by  Farbwercke Hoechst AC for the subs- 
tance Phenyl-1, 4-di-iso-thiocyanate, which has 
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the generic name : Bitoscanate, the molucular 
formula: C8H4N2S2 and the structural for- 
,nula : S = C = N - e - N = C = S. Jonit 
is insoluble in water, soluble in methanol and 
ethanol and easily soluble in chloroform. It 
is a white to  yellowish-white crystalline, almost 
odourless, tasteless powder. 
LD5, of Jonit in mice is 230 mg/kg and in 
rat 495 mg/kg (micronized substance). 25 mg/ 
kg and 50 mg/kg of the drug daily given for 
four and a half month did not reveal a leu- 
caemigenic or carcinogenic effects. Jonit 
cannot yet be regarded perfectly safe for use 
in children under 3 years of age or in pregnant 
women. A pronounced effect on the develop- 
ment of the larvae has been found. It has been 
clearly demonstrated, that Jonit is not only 
effective against mature worms, but reinfec- 
tion is not likely to  occur for a period of time 
after treatment. The results have shown, that 
a considerable amount of drug is absorbed in 
man (0.0072 f 0.0036 u mol/rnl, 24 hours 
after a dose of 100 mglsubject). The drug has 
shown to be effective in animals against Ne- 
matodes, Trematodes and Cestodes. It has also 
been found to  be equally effective against 
Necator mnericanus and Ancylostoma duo- 
denale. (3 ,4 ,9 )  
The present paper describes our experience 
with this drug in 60 out-patients suffering 
from hookworm infection. 
smear (for one sample 4 smears of each 2 mg 
fecal matter were made). Testtube cultures 
according to the Harada-Mori method were 
made to obtain some index of the frequency 
of the dominant hookworm species and of 
the hatching rate (a spread of ?h gram of fecal 
sample for each testtube). 
Follow-up examinations were done 2 to 4 
weeks after treatment. 
In order to identify the species, the hook- 
worms passed in the stools were collected by 
sieving one to two days after treatment. 
DOSAGE 
All patients received medication. The drug, 
in the form of gelatine capsules each contain- 
ing 50 mg Jonit, was to be swallowed with 
water after the evening meal. Coffee or alcoho- 
lic beverage should not be taken at the same 
time, as it might reduce tolerance to the drug. 
No measures like fasting, diet or purging 
were necessary. 
The dose schedule for a single dose treat- 
ment as recommanded was : 
Age Single dose 
- - 
3 - 10 years 
11 - 15 years 
> 16 years 
I capsule 
2 capsules 
3 capsules 
MATERIALS AND METHODS 
The cases were selected from school-chil- 
dren, students and lecturers of some faculties 
of the Hasanuddin University. 
A total of 304 persons were screened and 
60 of them were taken in our study, who had 
an egg count varying between 500 to  5000 eggs 
per gram (checked with the McMaster counting 
method). 
The age of the patients ranged from 5 to  
50 years. All patients were out-patients. 
The diar:oses were made with the direct 
There were 11 patients ranging between 
5 - 10 years of age in group I ,  13 patients 
ranging between 1 1 - 15 years of age in group 
11 and 36 patients ranging between 16 - 50 
years of age in group 111. 
RESULTS 
In the first group parasitological cure was 
achieved in 9 cases out of the 1 1 cases (8 1.8 %), 
while 2 cases remained positive. however with 
an egg reduction count of 87.6 7%. 2 4 weeks 
after treatment. (Table 1 ) 
PI-IENYLENE Di--ISOTHIOCYANATE (1,4) OR JONIT IN THE TREATMENT O F  HOOKWORM 
Table 1 .  Results of a single dose Jonit Treatment in Hookworm infection. 
Parasit. Cure Rate Average % 
Group Number of cases 
Egg Reduction 
Number % 
Total 60 52 86.7 85.1 
In the second group parasitological cure 
was obtained in 12 cases out of the 13 cases 
(92.3 %), while one case remained positive 
with an egg reduction count of 83.4 %, 2 - 4 
weeks after treatment. 
In the third group parasitological cure was 
found in 26 cases out of the 36 cases (86.1 %), 
while 10 cases remained positive with an egg 
reduction count of 84.7 %, 2 - 4 weeks after 
treatment. 
The overall parasitological cure rate was 
86.7 76, and the average egg reduction count 
was 85.1 %. 
According to the Harada-Mori test 90  % out 
of 60 cases were infected with Necator ameri- 
canus solely and 10 % had a mixed infection 
with Necator americanus and Ancylostoma 
duodenale. (Table 2 )  
Table 2. Results of a single dose Jonit treatment in 60 patients 
with a single and mixed hookworm infection. 
Na. = Necator americanus A.d. = Ancylostoma duodenale 
A cure rate of 85.1 % in 54 cases with neca- An average of 93.0 % hatching rate reduc- 
toriasis was achieved. A 100 5% cure rate in 10 tion of hookworm larvae was found in 60 
cases with mixed infection was found; the patients after Jonit treatment. (Table 3) 
number of cases however was limited. (Table 2) 
A.d. 
0 
0 
0 
Table 3. Hookworr~i larvae encountered in 60 patients before and after 
Jonit treatment according to  the Harada Mori test. 
2-4 weeks after treatment with 
Patients 
N.a. 
2 
1 
5 
8 (85.1 %) 
Before treatment with 
Group 
I 
I I 
I I I 
Total 
A.a. + A.d. 
0 
0 
0 
0 (100%) 
No. 
11 
13 
36 
60 
Hatching Rate 
Reduction 
94.2 % 
94.6 % 
91.5 % 
93.0 % 
A.d. 
0 
0 
0 
N.a. 
10 
11 
33 
54 (90 %) 
N.a. + A.d. 
1 
2 
3 
6 (10%) 
After treatment larvae of Patients 
N.a. 
16 
14 
44 
7 4 
Before treatment larvae of 
Group 
I 
I I 
I l l  
Total 
A.d. 
0 
0 
0 
0 
N a. 
249 
240 
48 1 
970 
No. 
11 
13 
36 
60 
A.d. 
30 
2 1 
4 1 
92 
K. ABADl dkk. 
Side effects like nausea, diarrhoea, vomiting, We encountered more Necator americanus 
abdominal discomfort and dizziness were mild than Ancylostoma duoderzale adults in the 
and transient on the first day of treatment and fecal specimens one to two days after treat- 
no special treatment was required. (Table 4) ment. 
DISCUSSION 
Table 4. Side effects with a single dose Jonit treatment (60 cases) 
Results obtained in our trial correspond well 
with those obtained by other investigators, 
even in cases where other methods, different 
dosage schedules and fecal examination techni- 
que were applied. 
Bhandari and Singh in India (1969), using 
a single dose of 150 mg Jonit treatment, re- 
ported a 50 % cure rate with an average of 87 - 
9 1% egg reduction. A dose schedule of 2 X 150 
mg Jonit resulted in a 50 5% cure rate and an 
average reduction rate of 75 %, while a 3 X 100 
mg dose applied every 24  hours to  adults re- 
sulted in a 92 % cure rate and a 90 % egg reduc- 
tion rate. 
Mutalik et al., in India (1969) achieved a 
50 % cure rate and an average of 77% egg re- 
duction with a dose schedule of 2 X 100 mg 
Jonit t o  5 - 9 years of age patients, a 85% 
cure rate and an average of 94% egg reduction 
with a dose schedule of 3 X 100 mg every 24 
hours to 10 - 14 years of age patients, and a 
74% cure rate and an average of 91% egg re- 
duction with a dose schedule of 3 X 100 mg 
every 12 hours to patients more than 15 years 
old. 
Sookasen et al., in Thailand (1972) in their 
clinical trial with a single dose of Jonit obtained 
a 90% cure rate and a 96.6% egg reduction to 
patients having 1 -- 2000 eggs per gram feces, 
a cure rate of 50% and an average of 94.2% 
egg reduction to  patients having 2001 - 5000 
e.p.g. feces, and a cure rate of 74 % and an ave- 
rage of 88.3 % egg reduction to patientihaving 
more than 5000 e.p.g. feces. 
O'Holohan et al., in Malaysia (1972) carried 
out a clinical trial with a single dose of Jonit 
according to age. They confirmed a 66.6% 
cure rate with an average of 8 0  - 9 0  % egg re- 
duction rate to patients having 1 2000 e.p.g. 
faeces, a 53.8% cure rate with an average of 
82 - -  90 % egg reduction rate to patients having 
2000 - 3000 e.p.g. feces, a 40.0% cure rate 
with an average of 84 - 90 %' egg reduction rate 
to  patients having 3000 - 4000 e.p.g. feces, 
and a 22.2% cure rate with an average of 95 % 
egg reduction rate to patients having 5000 - 
10,000 e.p.g. faces. 
Idris in Jakarta (1976) Found a 69% cure 
rate with and average of 7.31% egg reduction 
to patients having 1 - 21 e.p.g. feces, a 27 % 
cure rate with an average of 79.5% egg reduc- 
tion to  patients having 2100 - -  5000 e.p.g. fe- 
ces, and a 44.4% cure rate with an average of 
93.3% egg reduction to patients having morc 
than 5000 e.p.g. feces, with a single dose 150 
mg Jonit treatment to adult patients. 
In general from the above mentioned results 
can be concluded, that the lesser the egg count 
the higher cure rate could be achieved. The 
ageldosage ratio has also to be taken into ac- 
count. Statements on cure rates can vary c!ue 
t o  the possibility of missing a small number 
of eggs that might be passed after treatment. 
The most valuable information on the effi- 
cacy of Jonit obtained by t11: experiment is 
the high average egg reduction after treatment. 
The high cure rates found in necatoriasis 
and mixed infection ?lave aisc, ~hown,  that Jonit 
is an effective agent in a single dose regimen, 
equally effective against Necator anzericanus 
% 
26.6 
33.3 
26.6 
25.0 
21.6 
Total 
16 
20 
16 
15 
13 
Group I l l  
6 
14 
10 
6 
7 
Group I I  
5 
3 
3 
5 
4 
Symptoms 
Nausea 
Diarrhoea 
Vomiting 
Abdom. discomfort 
Dizziness 
Group I 
4 
3 
3 
4 
2 
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and Ancylostoma duodenale. 
The significantly high average hatching re- 
duction rate in comparison t o  the average re- 
duction rate, is probably due to  the effect of 
Jonit hampering the development of hook- 
worm eggs or larvae. However, more investiga- 
tions are needed to verify this. 
Diarrhoea was the most common side effect 
encountered in this trial and most patients ap- 
peared to accept it as a visible evidence, that 
the drug was working to expel the worms. 
The result of this clinical trial suggests, that 
single dose regimens of Jonit would be useful 
in mass erradi:ation schemes for the control 
of hookworms. 
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